Insight Molecular Analyst Price Targets - Benzinga

Insight Molecular Diagnostics Inc

IMDXNASDAQ

Trade with Public

Trade with Public

$4.01

0.010.25%

At close: Sep 21, 5:00 PM EST

$3.97

-0.04-1%

After Hours: 7:02 PM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Insight Molecular Analyst Price Targets

Wall Street analyst price targets and consensus rating for Insight Molecular (IMDX).

Price Target Range — 4 Quarters

Analyst Consensus — 3 Analysts

3Buy

Consensus RatingBuy# Analysts3Avg. Consensus PT$10Upside to Avg. PT+143.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 24, 2026	LUCID CAPITAL MARKETS	Alex Nowark	Initiate	Buy	$8
Aug 18, 2026	Needham	Mike Matson	Maintained	Buy	$9
Feb 17, 2026	Lake Street	Thomas Flaten	PT Raise	Buy	$8→$12
Nov 11, 2025	Needham	Mike Matson	PT Raise	Buy	$4→$9
Aug 18, 2025	Needham	Mike Matson	Maintained	Buy	$4

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Insight Molecular with Buy Rating, Announces Price Target of $8

LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Insight Molecular (NASDAQ:IMDX) with a Buy rating and announces Price Target of $8.

Benzinga Newsdesk

PRO
Needham Reiterates Buy on Insight Molecular, Maintains $9 Price Target

Needham analyst Mike Matson reiterates Insight Molecular (NASDAQ:IMDX) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on Insight Molecular, Raises Price Target to $12

Lake Street analyst Thomas Flaten maintains Insight Molecular (NASDAQ:IMDX) with a Buy and raises the price target from $8 to $12.

Benzinga Newsdesk

PRO
Needham Maintains Buy on Insight Molecular, Raises Price Target to $9

Needham analyst Mike Matson maintains Insight Molecular (NASDAQ:IMDX) with a Buy and raises the price target from $4.25 to $9.

Benzinga Newsdesk

PRO
Needham Reiterates Buy on Insight Molecular, Maintains $4.25 Price Target

Needham analyst Mike Matson reiterates Insight Molecular (NASDAQ:IMDX) with a Buy and maintains $4.25 price target.

Benzinga Newsdesk